TG Forum Logo TG Forum Logo

Phase 2, dose-ranging study of vupanorsen in patients with diabetes, hepatic steatosis and hypertriglyceridaemia (NCT03371355)

You are here: Home > Trials

Please login or create a FREE account to view this content

Educational partners and supporters

Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Arrowhead Pharmaceuticals
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Ionis Logo
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc. Kowa Logo